BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18629778)

  • 41. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals.
    Ng EK; Tsui NB; Lam NY; Chiu RW; Yu SC; Wong SC; Lo ES; Rainer TH; Johnson PJ; Lo YM
    Clin Chem; 2002 Aug; 48(8):1212-7. PubMed ID: 12142376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequence-specific histone methylation is detectable on circulating nucleosomes in plasma.
    Deligezer U; Akisik EE; Erten N; Dalay N
    Clin Chem; 2008 Jul; 54(7):1125-31. PubMed ID: 18487283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Telomerase RNA as a detection marker in the serum of breast cancer patients.
    Chen XQ; Bonnefoi H; Pelte MF; Lyautey J; Lederrey C; Movarekhi S; Schaeffer P; Mulcahy HE; Meyer P; Stroun M; Anker P
    Clin Cancer Res; 2000 Oct; 6(10):3823-6. PubMed ID: 11051224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a real-time PCR assay for the diagnosis of Pneumocystis pneumonia.
    Etoh K
    Kurume Med J; 2008; 55(3-4):55-62. PubMed ID: 19571493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison between real-time quantitative PCR detection of HER2 mRNA copy number in peripheral blood and ELISA of serum HER2 protein for determining HER2 status in breast cancer patients.
    Savino M; Parrella P; Copetti M; Barbano R; Murgo R; Fazio VM; Valori VM; Carella M; Garrubba M; Santini SA
    Cell Oncol; 2009; 31(3):203-11. PubMed ID: 19478388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated HGF levels in sera from breast cancer patients detected using a protein microarray ELISA.
    Woodbury RL; Varnum SM; Zangar RC
    J Proteome Res; 2002; 1(3):233-7. PubMed ID: 12645900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
    Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
    Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased glyceraldehyde-3-phosphate dehydrogenase expression in renal cell carcinoma identified by RNA-based, arbitrarily primed polymerase chain reaction.
    Vilà MR; Nicolás A; Morote J; de I; Meseguer A
    Cancer; 2000 Jul; 89(1):152-64. PubMed ID: 10897012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer.
    Shaw JA; Brown J; Coombes RC; Jacob J; Payne R; Lee B; Page K; Hava N; Stebbing J
    Biomark Med; 2011 Feb; 5(1):87-91. PubMed ID: 21319970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
    Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
    J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.
    Wang-Johanning F; Li M; Esteva FJ; Hess KR; Yin B; Rycaj K; Plummer JB; Garza JG; Ambs S; Johanning GL
    Int J Cancer; 2014 Feb; 134(3):587-95. PubMed ID: 23873154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitochondrial DNA content in paired normal and cancerous breast tissue samples from patients with breast cancer.
    Fan AX; Radpour R; Haghighi MM; Kohler C; Xia P; Hahn S; Holzgreve W; Zhong XY
    J Cancer Res Clin Oncol; 2009 Aug; 135(8):983-9. PubMed ID: 19125299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus.
    Biesen R; Dähnrich C; Rosemann A; Barkhudarova F; Rose T; Jakob O; Bruns A; Backhaus M; Stöcker W; Burmester GR; Schlumberger W; Egerer K; Hiepe F
    Arthritis Res Ther; 2011 Feb; 13(1):R26. PubMed ID: 21329504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Free circulating tumor DNA as a diagnostic marker for breast cancer.
    Hashad D; Sorour A; Ghazal A; Talaat I
    J Clin Lab Anal; 2012 Nov; 26(6):467-72. PubMed ID: 23143630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
    Williams RC; Malone CC; Meyers C; Decker P; Muller S
    J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
    Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
    Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.
    Matuschek C; Bölke E; Lammering G; Gerber PA; Peiper M; Budach W; Taskin H; Prisack HB; Schieren G; Orth K; Bojar H
    Eur J Med Res; 2010; 15(7):277-86. PubMed ID: 20696638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation.
    Pumannova M; Roubalova K; Vitek A; Sajdova J
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):115-20. PubMed ID: 16406183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker.
    Kamat AA; Baldwin M; Urbauer D; Dang D; Han LY; Godwin A; Karlan BY; Simpson JL; Gershenson DM; Coleman RL; Bischoff FZ; Sood AK
    Cancer; 2010 Apr; 116(8):1918-25. PubMed ID: 20166213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HSP70 as a Diagnostic and Prognostic Marker in Egyptian Women With Breast Cancer.
    Fahim HH; Mohamed G; Safwat G; Abo-Bakr A; Ibraheem MH; Al-Mofty S; Kamel MM; Abdel-Moneim AS; Gameel AM
    Clin Breast Cancer; 2021 Jun; 21(3):e177-e188. PubMed ID: 33323333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.